1. ¹Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, Utah
2. ²Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, Utah

Correspondence: Lester Layfield, M.D., Department of Pathology, University of Utah Health Sciences Center, School of Medicine, 50 North Medical Drive, Salt Lake City, UT 84132; e-mail: layfield@arup-lab.com; fax: 801-585-3831.

Accepted 6 July 2001.

Abstract

Malignant mesenchymal neoplasms of the pancreas are rare and malignant islet cell tumors with sarcomatous dedifferentiation are rarer still. We present a case of malignant islet cell tumor with sarcomatous differentiation, which to our knowledge is only the second reported case showing such a combination of morphologic features. Clinically, the neoplasm was not hormonally active and immunohistochemical staining was negative for gastrin, glucagon, insulin and somatostatin. The sarcomatous component strongly reacted with an antibody directed against vimentin, and a minority of cells stained strongly with antisera directed against desmin and smooth muscle actin. The spindle cell component was nonreactive with antibodies directed against Factor VIII. The myogenous direction of differentiation in the present tumor is similar to that seen in the prior case report of malignant islet cell tumor with rhabdomyosarcomatous differentiation.